When the \"strongest brains\" in the field of pharmaceutical innovation and investment gather in the New District, what kind of cutting-edge insights will they bring? Why did the pharmaceutical industry choose to organize this event in the New District?<\/p>\n\n\n\n 0<\/strong>1<\/strong>Ten years, first landing in Nanjing<\/strong><\/p>\n\n\n\n When it comes to the biomedical industry, it seems that the two key words \"innovation\" and \"investment\" are always inseparable.<\/p>\n\n\n\n Innovation is the source of industrial development, from the discovery of brand-new targets to the birth of revolutionary therapies; and investment is the key to turning cutting-edge technologies into universal products, supporting a new drug through the long R&D and clinical cycle.<\/p>\n\n\n\n The Pharmaceutical Innovation and Investment Conference combines these two keywords. Since its inaugural meeting in 2016, the conference has focused on exploring global pharmaceutical innovation trends and building a cooperation platform for \"government, industry, academia, research, application and finance\".It has become a \"wind vane\" for domestic pharmaceutical innovation and investment.<\/strong>The<\/p>\n\n\n\n In its 10th year, the conference has landed in Nanjing for the first time, coming to the new district, and also bringing more forward-looking topics.<\/p>\n\n\n\n The 2-day conference features many sub-forums focusing on new anti-tumor drugs, gene and cell therapy, AI-enabled pharmaceutical R&D and other cutting-edge areas, as well as covering popular topics such as nuclear drugs, weight reduction innovative drugs, and children's drugs, which will be shared by renowned scientists and heads of pharmaceutical companies.<\/p>\n\n\n\n While exploring industry trends, the conference also has a more open ecology. What are the modes of authorizing innovative drugs to go overseas? How can commercial insurance support the development of innovative drugs? What are the new trends in health insurance payment reform? Various policy interpretations, investment and financing strategies, industry insights and decision-making references, pointing the way for innovation. On-site roadshow and enterprise exhibition area are also set up to provide precise docking opportunities for technology and capital.<\/p>\n\n\n\n It is worth noting thatThe \"Nanjing Jiangbei New Area - Hong Kong Biomedical Industry Exchange Meeting\" is also an important sub-session of this conference.<\/strong>The Hong Kong delegation had in-depth exchanges with representatives of enterprises and investment and financing institutions in the new district. Hong Kong \"delegation\" and the new area business representatives, investment and financing institutions and other in-depth exchanges, talk about the development of the biomedical industry. New sparks collided and new waves emerged. A conference, focusing on \"Venture Capital\", the national pharmaceutical gurus gathered, not only for the development of the innovative drug industry to accelerate, but also become a showcase for the vitality of the regional industry--...As the organizer of this conference, the new district life and health industry development momentum is also hot, is becoming a lot of \"medicine people\" of the convergence of eyes!<\/strong>The<\/p>\n\n\n\n For example, on the eve of the General Assembly, a \"mystery tour\" composed of participating guests, into the new area of biomedical valley. Most of the guests \"came here\", the site exchanges warmly.<\/p>\n\n\n\n The park, which covers a total area of 20.51 square kilometers, is home to more than 1,300 biomedical enterprises and ranks 8th in the country in terms of overall competitiveness. to date, the park has listed 402 pharmaceutical products and 1,261 medical device products, including6 new class I drugs, more than 50 product technologies are the first of their kind at home and abroad.<\/strong>The results are bright enough. In the high-tech, high-investment, long-cycle biomedical industry, such achievements are bright enough.<\/p>\n\n\n\n Innovation and vitality continue to flow, and in the capital market, the new area \"engine\" also continues to roar: in June this year, the new area enterprises Pharmacare Ankang listed on the main board of the Hong Kong Stock Exchange; only a month after the opening of the Vigilance ChiBo gong once again stirred the Xiangjiang River; from Pharmacare Ankang is only a 6-minute drive, Pharmacare Biologicals has set a record five years after its establishment, that is, the listing of the \"industry myth\"! \"Industry Myth\" ......<\/p>\n\n\n\n At present, the new drug valley has independently cultivated listed enterprises<\/strong>7. Looking at the drug valley \"listed reserves\", there are more than a dozen seed players are \"lined up\" to break through the IPO, should be the biological, pharmaceutical has been handed over to the table of Hong Kong stocks.<\/strong>Pharmaceutical Valley enterprises \"ladder orderly, successive listing\" of the good situation, is attracting more attention.<\/p>\n\n\n\n With cutting-edge innovations and the ability to win the attention of the capital market, it is self-evident why this conference was chosen to be held in the new district.<\/p>\n\n\n\n This is from the industry's recognition, but also paved the way for more expectations: these big names in the pharmaceutical industry from afar, but also for this hot spot to inject more confidence and vitality. New opportunities for cooperation, new projects landing, the north bank of the Yangtze River, a more competitive biomedical industry cluster is rising.<\/p>\n\n\n\n <\/p>","protected":false},"excerpt":{"rendered":" October, the weather is getting cooler, but Jiangbei \"heat\" remains. This morning, the tenth pharmaceutical innovation and investment conference in the new district opened. The conference, organized by the China Pharmaceutical Innovation [....]<\/p>","protected":false},"author":2,"featured_media":14138,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[84],"tags":[],"class_list":["post-14133","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-chan_ye_lian_xun_xi"],"acf":[],"yoast_head":"\n![\"\"](\"https:\/\/www.tigerandtech.com\/wp-content\/uploads\/2025\/10\/11-4-1024x684.png\")
<\/figure>\n\n\n\n![\"\"](\"https:\/\/www.tigerandtech.com\/wp-content\/uploads\/2025\/10\/222-4-1024x682.jpg\")
<\/figure>\n\n\n\n
0<\/strong>2<\/strong>Here, companies are lining up to go public.<\/strong><\/p>\n\n\n\n![\"\"](\"https:\/\/www.tigerandtech.com\/wp-content\/uploads\/2025\/10\/333-3-1024x635.jpg\")
<\/figure>\n\n\n\n![\"\"](\"https:\/\/www.tigerandtech.com\/wp-content\/uploads\/2025\/10\/444-2-1024x683.jpg\")
<\/figure>\n\n\n\n![\"\"](\"https:\/\/www.tigerandtech.com\/wp-content\/uploads\/2025\/10\/555-2-1024x767.jpg\")
<\/figure>\n\n\n\n